Subscribe to RSS
DOI: 10.1055/a-1164-9381
COVID-19: ophthalmologische Aspekte der globalen SARS-CoV-2-Pandemie
Article in several languages: English | deutschPublication History
received 18 April 2020
accepted 23 April 2020
Publication Date:
06 May 2020 (online)
Zusammenfassung
Einleitung Ein substanzieller Teil der aktuellen Literatur zur COVID-19-Pandemie beschäftigt sich mit deren ophthalmologischen Aspekten. In diesem Übersichtsartikel soll ein Überblick über die bisher publizierten Studien gegeben werden, die für die Ophthalmologie relevant sind.
Material und Methoden PubMed.gov wurde systematisch nach Artikeln mit den folgenden Schlüsselwörtern durchsucht: „COVID-19“, „Coronavirus“ und „SARS‐CoV‐2“ in Verbindung mit „Ophthalmology“ und „Eye“. Darüber hinaus wurde eine Analyse der Empfehlungen der ophthalmologischen Fachgesellschaften durchgeführt, insbesondere der American Academy of Ophthalmology (AAO) und des Royal College of Ophthalmologists (RCOphth).
Ergebnisse Es wurden 21 Artikel mit Peer Review zu den ophthalmologischen Aspekten von COVID-19 identifiziert (Stand: 16. April 2020). Davon stammten 12 (57,1%) aus Asien, 6 (28,6%) aus den Vereinigten Staaten und 3 (14,3%) aus Europa. Darunter befanden sich 5 Originalarbeiten (23,8%), 10 (47,6%) Briefe an den Herausgeber, 3 (14,2%) Fallberichte und 3 (14,2%) Übersichtsartikel. Es erfolgte eine Sortierung in folgende Themen: „(Okuläre) Übertragungswege und Prävention“, „Ophthalmologische Manifestation von COVID-19“, „Klinische Richtlinien für die ophthalmologische Praxis während der COVID-19-Pandemie“ und „Praktische Empfehlungen für den klinischen Alltag“. Letztere wurden den Empfehlungen der AAO und des RCOphth entnommen.
Schlussfolgerungen Eine Vielzahl kürzlich erschienener Artikel befasst sich mit den ophthalmologischen Aspekten von COVID-19. Da COVID-19 über das Auge übertragen werden kann (aktiv über die Tränenflüssigkeit und passiv über den Ductus nasolacrimalis), ist eine sorgfältige Infektionsprävention in der ophthalmologischen Praxis von großer Bedeutung. Eine Augenbeteiligung kann sich als Keratokonjunktivitis manifestieren.
-
References/Literatur
- 1 Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed 2020; 91: 157-160 doi:10.23750/abm.v91i1.9397
- 2 Parrish II RK, Stewart MW, Duncan Powers SL. Ophthalmologists Are More Than Eye Doctors – In Memoriam Li Wenliang. Am J Ophthalmol
- 3 Sommer A. Humans, Viruses, and the Eye-An Early Report from the COVID-19 Front Line. JAMA Ophthalmol 2020;
- 4 Che C. Europeʼs Doctors Repeat Errors Made in Wuhan, China Medics Say. Available at: https://www.bloomberg.com/news/articles/2020-03-17/europe-s-doctors-getting-sick-like-in-wuhan-chinese-doctors-say Accessed 14.04.2020
- 5 Wu P, Duan F, Luo C. et al. Characteristics of Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020;
- 6 Chen L, Liu M, Zhang Z. et al. Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease. Br J Ophthalmol 2020;
- 7 Minocha A, Sim SY, Than J. et al. Survey of ophthalmology practitioners in A&E on current COVID-19 guidance at three Major UK Eye Hospitals. Eye 2020;
- 8 Leung NHL, Chu DKW, Shiu EYC. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med 2020;
- 9 Bai Y, Yao L, Wei T. et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020;
- 10 Rothe C, Schunk M, Sothmann P. et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med 2020; 382: 970-971 doi:10.1056/NEJMc2001468
- 11 Centers for Disease Control and Prevention (CDC). Recommendation Regarding the Use of Cloth Face Coverings, Especially in Areas of Significant Community-Based Transmission. Available at: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover.html%23studies Accessed 14.04.2020
- 12 Klompas M, Morris CA, Sinclair J. et al. Universal Masking in Hospitals in the Covid-19 Era. N Engl J Med 2020;
- 13 Wan KH, Huang SS, Young A. et al. Precautionary measures needed for ophthalmologists during pandemic of the coronavirus disease 2019 (COVID-19). Acta Ophthalmol 2020;
- 14 Jacob S. Slit lamp breath protector – from Corona virus and other pathogens. Soosan Jacob with audio 2.5 min. Available at: https://www.youtube.com/watch?v=pXm624pBDUM Accessed 14.04.2020
- 15 van Doremalen N, Bushmaker T, Morris DH. et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med 2020; 382: 1564-1567 doi:10.1056/NEJMc2004973
- 16 Xia J, Tong J, Liu M. et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 2020;
- 17 Seah IYJ, Anderson DE, Kang AEZ. et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology 2020;
- 18 Zhou P, Yang XL, Wang XG. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579: 270-273 doi:10.1038/s41586-020-2012-7
- 19 Senanayake P, Drazba J, Shadrach K. et al. Angiotensin II and its receptor subtypes in the human retina. Invest Ophthalmol Vis Sci 2007; 48: 3301-3311 doi:10.1167/iovs.06-1024
- 20 Holappa M, Vapaatalo H, Vaajanen A. Many Faces of Renin-angiotensin System – Focus on Eye. Open Ophthalmol J 2017; 11: 122-142 doi:10.2174/1874364101711010122
- 21 Qing H, Li Z, Yang Z. et al. The possibility of COVID-19 transmission from eye to nose. Acta Ophthalmol 2020;
- 22 Liu Z, Sun CB. Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract. J Med Virol 2020;
- 23 Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020; 395: e39 doi:10.1016/S0140-6736(20)30313-5
- 24 Li JO, Lam DSC, Chen Y. et al. Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol 2020; 104: 297-298 doi:10.1136/bjophthalmol-2020-315994
- 25 Lai THT, Tang EWH, Chau SKY. et al. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefes Arch Clin Exp Ophthalmol 2020; 258: 1049-1055 doi:10.1007/s00417-020-04641-8
- 26 Ong SWX, Tan YK, Chia PY. et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a Symptomatic Patient. JAMA 2020;
- 27 Guan WJ, Ni ZY, Hu Y. et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;
- 28 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062 doi:10.1016/S0140-6736(20)30566-3
- 29 Cheema M, Aghazadeh H, Nazarali S. et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 2020;
- 30 Seah I, Agrawal R. Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocul Immunol Inflamm 2020; 28: 391-395 doi:10.1080/09273948.2020.1738501
- 31 Fineberg HV. Ten Weeks to Crush the Curve. N Engl J Med 2020; 382: e37 doi:10.1056/NEJMe2007263
- 32 American Academy of Ophthalmology. Recommendations for urgent and nonurgent patient care. Available at: https://www.aao.org/headline/new-recommendations-urgent-nonurgent-patient-care Accessed 16.04.2020
- 33 The Royal College of Ophthalmologists. Burdon M. COVID-19 clinical guidance for ophthalmologists. Available at: https://rcophth.ac.uk/2020/04/covid-19-update-and-resources-for-ophthalmologists/ Accessed 16.04.2020
- 34 Moorfields Eye Hospital. Ophthalmological Risk Stratification & Implementation Guidance. Available at: https://www.rcophth.ac.uk/wpcontent/uploads/2020/03/Moorfields-Ophthalmic-Risk-Stratification-Implementation-Guideline-V2.0.pdf Accessed 16.04.2020
- 35 American Academy of Ophthalmology. List of urgent and emergent ophthalmic procedures. Available at: https://www.aao.org/headline/list-of-urgent-emergent-ophthalmic-procedures Accessed 16.04.2020
- 36 The Royal College of Ophthalmologists. Medical Retinal Management Plans during COVID-19. Available at: https://www.rcophth.ac.uk/wp-content/uploads/2020/03/Medical-Retinal-Management-Plan-during-COVID-19-UPDATED-300320-1-3.pdf Accessed 16.04.2020
- 37 Borrelli E, Sacconi R, Querques L. et al. Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy. Eye (Lond) 2020;
- 38 Yu AY, Tu R, Shao X. et al. A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology. Eye Vis (Lond) 2020; 7: 19 doi:10.1186/s40662-020-00187-2
- 39 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506 doi:10.1016/s0140-6736(20)30183-5
- 40 Mao L, Jin H, Wang M. et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 2020;
- 41 Hopkins C, Surda P, Kumar N. Presentation of new onset anosmia during the COVID-19 pandemic. Rhinology 2020;
- 42 Walker A, Hopkins C, Surda P. The use of google trends to investigate the loss of smell related searches during COVID-19 outbreak. Int Forum Allergy Rhinol 2020;
- 43 Romano MR, Montericcio A, Montalbano C. et al. Facing COVID-19 in Ophthalmology Department. Curr Eye Res 2020;